drugset / Trial / NCT04162002

Restylane® Lyft Filler Injection for Hand Rejuvenation on First Impressions

NCT04162002 ↗

Phase 1 Completed 10 enrolled DeNova Research Galderma R&D · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research is to determine the effects of Restylane® Lyft Filler injection into the back of the hand on first impressions.

Timeline

Start
2019-10-10
Primary completion
2019-11-18
Completion
2019-11-18

Outcome

Met primary endpoint

release “The study met its primary endpoint, showing a clinically meaningful improvement in the correction of volume deficits of treated hands for up to six months.” galderma.com ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Restylane® Lyft Unknown — —

Indications

No indication recorded.